Three experiments investigated the mechanisms, correlates, and methods of immunization against interrogative suggestibility (IS). IS involves reliance in memory reports on suggestions contained in misleading questions (Yield) and the tendency to change answers under negative feedback about the quality of previous testimony (Shift). All three studies found that the milder version of the tool used in the studies (GSS) resulted in lower Yield and Shift. In analyses considering the memory states of the participants, IS was found to be highest when participants mistakenly attributed the information contained in the suggestive questions to the original material. However, significant percentages of the participants succumbed to suggestions and changed answers even when they were aware of the discrepancy between the original material and the information contained in the questions. The warning against suggestions was found to lower Yield and Shift, and this was especially true when participants were aware of discrepancies between original material and suggestions. Enhancing self-esteem and inducing mindfulness did not reduce IS. The correlations between IS, including IS in individual mindfulness states, with the Big Five personality traits, anxiety, susceptibility to influence, and self-esteem were inconsistent.

Correct diagnosis and appropriate selection of pharmacotherapy will not upgrade patient’s health if the drug is not available in the pharmacy. Pharmaceutical supply chain breakdown may occur due to epidemiological or political reasons. Then, the finished drug form factories located in Poland will not secure the drug supply. Thus, cooperation of the scientific community with the pharmaceutical and chemical industries is necessary to boost the domestic manufacturing of active pharmaceutical substances and substrates. Due to number of substances needed, the scale of national demand and the investments, the problem needs to be solved at European level. The Pharmaceutical Strategy for Europe is an important guidance in this regard. The aim of our paper is to review the current state, indicate solutions and initiate a discussion on the development of the synthesis of active pharmaceutical substances in Poland. We focused on small-molecular compounds, the national perspective and the relationship between the synthesis of active substances and protection of the natural environment. Point actions for investments in infrastructure as well as research and development are not enough. Thus, we propose to create a system supporting synthesis of active pharmaceutical substances in Poland.